Discover 1,092 paid clinical trials in South Carolina. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
South Carolina has a wide range of paid research studies actively seeking both healthy volunteers and those with particular health conditions. Major hubs in Charleston, Columbia, and Greenville provide access to innovative treatments and top-quality medical care.
Filter
1
Filter results
Results: 1,092
Pivotal Study for the Cardiac Performance System (CPS)
for
Cardiovascular Diseases
Location: Neptune City NJ, New York NY, Hackensack NJ,
Sponsor: Sensydia Corporation
Sex: All
Age: 18+
Code: NCT06870591
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
for
Acute Leukemia of Ambiguous Lineage,
Location: Scarborough ME, Boston MA, Providence RI, Worcester MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 1
Code: NCT06317662
Phase2, Recruiting
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
for
Cystic Fibrosis
Location: Boston MA, Worcester MA, New Hyde Park NY, Valhalla NY,
Sponsor: Nicole Hamblett
Sex: All
Age: 12+
Code: NCT06504589
Recruiting
An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca
for
Febrile Neutropenia, Non-myeloid Malignancy
Location: Myrtle Beach SC, Charlotte NC, Rock Hill SC
Sponsor: Coherus Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT04662892
Recruiting
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Get alerts for new trials in your area by subscribing now
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
for
NonSegmental Vitiligo
Location: St. John's, Halifax, Boston MA, Quebec, Woodbury NY,
Sponsor: Incyte Corporation
Sex: All
Age: 2 - 11
Code: NCT06548360
Phase3, Recruiting
TR(ACE) Assay Clinical Specimen Study
for
Carcinoma, Non-Small-Cell Lung, Breast Neoplasms
Location: East Setauket NY, Toms River NJ, Flemington NJ,
Sponsor: Biological Dynamics
Sex: All
Age: 21+
Code: NCT02934360
Recruiting
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
for
Sickle Cell Disease
Location: The Bronx NY, Staten Island NY, Baltimore MD,
Sponsor: Sanofi
Sex: All
Age: 10 - 65
Code: NCT06975865
Phase3, Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Sydney, Boston MA, Quebec, Massapequa NY, The Bronx NY,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06283966
Phase3, Recruiting
Strategy for Improving Stroke Treatment Response
for
Ischemic Stroke
Location: Boston MA, Providence RI, Hartford CT, New Haven CT,
Sponsor: Translational Sciences, Inc.
Sex: All
Age: 18+
Code: NCT05948566
Phase2, Recruiting
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Location: Brewer ME, Gloucester MA, South Weymouth MA, Beverly MA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06661720
Phase3, Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: New Haven CT, Quebec, New Brunswick NJ, Montreal,